Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831

PURPOSE: This study investigated the association between tumor MYC protein expression and disease-free survival (DFS) of patients randomized to receive chemotherapy alone (Arm A) or chemotherapy with sequential (Arm B) or concurrent trastuzumab (Arm C) in the N9831 (Alliance) adjuvant HER2+ trastuzu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Dueck, Amylou C., Reinholz, Monica M., Geiger, Xochiquetzal J., Tenner, Kathleen, Ballman, Karla, Jenkins, Robert B., Riehle, Darren, Chen, Beiyun, McCullough, Ann E., Davidson, Nancy E., Martino, Silvana, Sledge, George W., Kaufman, Peter A., Kutteh, Leila A., Gralow, Julie, Harris, Lyndsay N., Ingle, James N., Lingle, Wilma L., Perez, Edith A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3805021/
https://ncbi.nlm.nih.gov/pubmed/23965903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0558
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia